SI9420037A - Use of natural products and related synthetic compounds for the preparation of medicines for treatment of cardiovascular disease - Google Patents

Use of natural products and related synthetic compounds for the preparation of medicines for treatment of cardiovascular disease Download PDF

Info

Publication number
SI9420037A
SI9420037A SI9420037A SI9420037A SI9420037A SI 9420037 A SI9420037 A SI 9420037A SI 9420037 A SI9420037 A SI 9420037A SI 9420037 A SI9420037 A SI 9420037A SI 9420037 A SI9420037 A SI 9420037A
Authority
SI
Slovenia
Prior art keywords
bis
formula
methyl
optionally substituted
hydroxy
Prior art date
Application number
SI9420037A
Other languages
English (en)
Slovenian (sl)
Inventor
Don Basil Roufogalis
Charles Colin Duke
Qian Li
Original Assignee
Univ Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Sydney filed Critical Univ Sydney
Publication of SI9420037A publication Critical patent/SI9420037A/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
    • C07C39/16—Bis-(hydroxyphenyl) alkanes; Tris-(hydroxyphenyl)alkanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/14—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with at least one hydroxy group on a condensed ring system containing two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI9420037A 1993-06-03 1994-06-03 Use of natural products and related synthetic compounds for the preparation of medicines for treatment of cardiovascular disease SI9420037A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPL918193 1993-06-03

Publications (1)

Publication Number Publication Date
SI9420037A true SI9420037A (en) 1996-08-31

Family

ID=3776946

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9420037A SI9420037A (en) 1993-06-03 1994-06-03 Use of natural products and related synthetic compounds for the preparation of medicines for treatment of cardiovascular disease

Country Status (16)

Country Link
US (2) US5741821A (bg)
EP (1) EP0703780A4 (bg)
JP (1) JPH09502163A (bg)
KR (1) KR960702749A (bg)
CN (1) CN1124922A (bg)
BG (1) BG100166A (bg)
BR (1) BR9406747A (bg)
CA (1) CA2164317A1 (bg)
CZ (1) CZ318795A3 (bg)
FI (1) FI955786A (bg)
HU (1) HUT74174A (bg)
NO (1) NO954479L (bg)
PL (1) PL311810A1 (bg)
SI (1) SI9420037A (bg)
SK (1) SK147995A3 (bg)
WO (1) WO1994028886A1 (bg)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7582298A (en) 1997-05-19 1998-12-11 Johns Hopkins University School Of Medicine, The Tissue specific prodrug
US6545131B1 (en) 1997-05-19 2003-04-08 The Johns Hopkins University Tissue specific prodrug
US6504014B1 (en) 1997-05-19 2003-01-07 The John Hopkins University Tissue specific prodrug
US6538022B1 (en) 1997-09-24 2003-03-25 Orion Corporation Compounds for deactivating phospholamban function on Ca-ATPase (phopholamban inhibitors)
RU2137472C1 (ru) * 1998-10-12 1999-09-20 Тихоокеанский институт биоорганической химии Дальневосточного отделения РАН Лекарственный препарат "гистохром" для лечения острого инфаркта миокарда и ишемической болезни сердца
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
JP2002541859A (ja) * 1999-04-15 2002-12-10 デフヘン・ナムローゼ・フェンノートシャップ 化合物スクリーニング方法
US7053042B1 (en) 1999-07-29 2006-05-30 Samuel Denmeade Activation of peptide prodrugs by hK2
US6541510B2 (en) * 2000-09-28 2003-04-01 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
WO2002026224A2 (en) * 2000-09-28 2002-04-04 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
EP1206934A1 (en) * 2000-11-15 2002-05-22 B. Braun Melsungen Ag Blockade of sodium channels by phenol derivatives
KR100704299B1 (ko) * 2005-11-17 2007-04-09 한국생명공학연구원 신규한 퀴놀린계 화합물, 및 지네 추출물 또는 이로부터 분리된 화합물을 포함하는 심장순환계 질환의 예방 및 치료용 조성물
US9024273B2 (en) * 2010-04-20 2015-05-05 Varian Semiconductor Equipment Associates, Inc. Method to generate molecular ions from ions with a smaller atomic mass

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2321620A (en) * 1940-10-10 1943-06-15 Du Pont Phenolic compounds
DE3527862A1 (de) * 1985-08-02 1987-02-05 Bayer Ag Verfahren zur herstellung von bis-hydroxyphenyl-n-alkanen, neue bis-hydroxyphenyl-n-alkane und neue alkandione

Also Published As

Publication number Publication date
EP0703780A1 (en) 1996-04-03
NO954479D0 (no) 1995-11-08
CN1124922A (zh) 1996-06-19
EP0703780A4 (en) 1998-01-07
FI955786A0 (fi) 1995-12-01
CA2164317A1 (en) 1994-12-22
FI955786A (fi) 1996-01-29
BR9406747A (pt) 1996-04-02
KR960702749A (ko) 1996-05-23
WO1994028886A1 (en) 1994-12-22
HU9503441D0 (en) 1996-01-29
US5859067A (en) 1999-01-12
CZ318795A3 (en) 1996-06-12
JPH09502163A (ja) 1997-03-04
NO954479L (no) 1996-02-02
BG100166A (bg) 1996-11-29
US5741821A (en) 1998-04-21
PL311810A1 (en) 1996-03-18
SK147995A3 (en) 1997-04-09
HUT74174A (en) 1996-11-28

Similar Documents

Publication Publication Date Title
KR101236527B1 (ko) 이핵성 효소의 강력한 저해제로서의 디아릴알칸
Giacomini et al. The use of stilbene scaffold in medicinal chemistry and multi-target drug design
JP2558131B2 (ja) コンブレタスタチン類
SI9420037A (en) Use of natural products and related synthetic compounds for the preparation of medicines for treatment of cardiovascular disease
US20070099826A1 (en) Treatment of diseases associated with the egr-1 enhancer element
US20050080024A1 (en) Nitric oxide donating derivatives for the treatment of cardiovascular disorders
KR101907716B1 (ko) 프레닐화된 하이드록시스틸벤
JPH01501791A (ja) 薬理学的に活性な化合物およびそれらの混合物、有機組成物および金属塩類
Zamrus et al. Design, synthesis and cytotoxic effects of curcuminoids on HeLa, K562, MCF-7 and MDA-MB-231 cancer cell lines
US20050080021A1 (en) Nitric oxide donating derivatives of stilbenes, polyphenols and flavonoids for the treatment of cardiovascular disorders
Khan et al. Synthesis and antihepatotoxic activity of some new chalcones containing 1, 4-dioxane ring system
Iwata et al. Antitumorigenic activities of chalcones. I. Inhibitory effects of chalcone derivatives on 32Pi-incorporation into phospholipids of HeLa cells promoted by 12-O-tetradecanoyl-phorbol 13-acetate (TPA)
Grealis et al. Synthesis of isobavachalcone and some organometallic derivatives
Leong et al. Asymmetrical meta-methoxylated diarylpentanoids: Rational design, synthesis and anti-cancer evaluation in-vitro
Osifová et al. Diketo–ketoenol tautomers in curcuminoids: Synthesis, separation of tautomers, and kinetic and structural studies
AU694428B2 (en) Use of natural products and related synthetic compounds for the treatment of cardiovascular disease
Herrmann et al. Synthesis of Phenyl‐1‐benzoxepinols Isolated from Butcher's Broom and Analogous Benzoxepines
EP4345098A1 (en) Conversion of cannabidiol to cannabinol using xylene
Kamma et al. Synthetic Studies toward 5, 6, 7, 3′, 4′-Monomethoxytetrahydroxyflavones: Synthesis of Pedalitin
de Jesus Haloaryl Secondary Metabolites from Macroalgae as Models for the Synthesis of Brominated Chalcones and their Derivatives
Joseph et al. Analgesic and Anti-Oxidant Activities of Certain (E)-3 Arylidene Flavanones Synthesized by One Pot Method
Eiffe The synthesis of novel, biologically active isoflavone analogues
Mustafa Synthesis and Biological Activity of Amino Acetylenic Coumarin Derivatives
Brookes Chemical investigation of isihlambezo or traditional pregnancy-related medicines.
JP2007131637A (ja) 治療剤